CD1-MR1 2025 , ,
Presentations this author is a contributor to:
Development of CAR-iNKT cells for the treatment and haematological malignancies and solid tumours (#187)
3:20 PM
Robson Dossa
Therapy of Cancer and Other Diseases 2